Violeta Šoljić

460 total citations
36 papers, 328 citations indexed

About

Violeta Šoljić is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Violeta Šoljić has authored 36 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology. Recurrent topics in Violeta Šoljić's work include Renal and related cancers (5 papers), Neonatal Respiratory Health Research (5 papers) and Pregnancy and preeclampsia studies (4 papers). Violeta Šoljić is often cited by papers focused on Renal and related cancers (5 papers), Neonatal Respiratory Health Research (5 papers) and Pregnancy and preeclampsia studies (4 papers). Violeta Šoljić collaborates with scholars based in Bosnia and Herzegovina, Croatia and Canada. Violeta Šoljić's co-authors include Katarina Vukojević, Mirna Saraga‐Babić, Marko Ostojić, Natalija Filipović, Merica Glavina Durdov, Vesna Čapkun, Sandra Zekić Tomaš, Nenad Kunac, Jelena Todorović and Marijan Saraga and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Orthopaedic Research® and Frontiers in Pharmacology.

In The Last Decade

Violeta Šoljić

33 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Violeta Šoljić Bosnia and Herzegovina 11 155 55 51 45 35 36 328
Takuya Hirai Japan 10 94 0.6× 68 1.2× 26 0.5× 46 1.0× 51 1.5× 28 326
Ryoji Yamakawa Japan 14 148 1.0× 75 1.4× 51 1.0× 32 0.7× 33 0.9× 54 679
Mikael Laine Finland 12 80 0.5× 47 0.9× 32 0.6× 38 0.8× 70 2.0× 19 397
Shaida Ouladan Canada 8 187 1.2× 47 0.9× 48 0.9× 58 1.3× 69 2.0× 9 529
Chie Watanabe Japan 9 92 0.6× 32 0.6× 17 0.3× 64 1.4× 31 0.9× 26 359
Şefık Güran Türkiye 11 91 0.6× 41 0.7× 23 0.5× 19 0.4× 81 2.3× 50 318
Sushmita Chakraborty India 12 84 0.5× 23 0.4× 65 1.3× 126 2.8× 16 0.5× 22 348
Hiroo Amano Japan 13 82 0.5× 43 0.8× 30 0.6× 93 2.1× 24 0.7× 48 437
Natalia V. Voronova Russia 9 137 0.9× 17 0.3× 38 0.7× 82 1.8× 78 2.2× 12 322

Countries citing papers authored by Violeta Šoljić

Since Specialization
Citations

This map shows the geographic impact of Violeta Šoljić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Violeta Šoljić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Violeta Šoljić more than expected).

Fields of papers citing papers by Violeta Šoljić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Violeta Šoljić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Violeta Šoljić. The network helps show where Violeta Šoljić may publish in the future.

Co-authorship network of co-authors of Violeta Šoljić

This figure shows the co-authorship network connecting the top 25 collaborators of Violeta Šoljić. A scholar is included among the top collaborators of Violeta Šoljić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Violeta Šoljić. Violeta Šoljić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brizić, Ivica, et al.. (2025). Decreased Endothelial Progenitor Cells Are Associated with Severe Coronary Artery Disease: Insights from a Clinical Study. Journal of Cardiovascular Development and Disease. 12(4). 132–132.
2.
Šoljić, Violeta, et al.. (2024). Identifying an Inversin as a Novel Prognostic Marker in Patients with Clear-Cell Renal Cell Carcinoma. International Journal of Molecular Sciences. 25(22). 12120–12120. 1 indexed citations
3.
Šoljić, Violeta, et al.. (2023). Spatio-Temporal Expression Pattern of CAKUT Candidate Genes DLG1 and KIF12 during Human Kidney Development. Biomolecules. 13(2). 340–340. 8 indexed citations
4.
Vukojević, Katarina, et al.. (2023). Expression Patterns of Serotonin Receptors 5-HT1A, 5-HT2A, and 5-HT3A during Human Fetal Lung Development. International Journal of Molecular Sciences. 24(3). 2965–2965. 4 indexed citations
5.
Filipović, Natalija, Ljubo Znaor, Nenad Kunac, et al.. (2022). Expression of Cell Cycle Markers and Proliferation Factors during Human Eye Embryogenesis and Tumorigenesis. International Journal of Molecular Sciences. 23(16). 9421–9421. 4 indexed citations
6.
Šoljić, Violeta, et al.. (2022). The Interplay of Cx26, Cx32, Cx37, Cx40, Cx43, Cx45, and Panx1 in Inner-Ear Development of Yotari (dab1−/−) Mice and Humans. Biomedicines. 10(3). 589–589. 2 indexed citations
7.
Filipović, Natalija, et al.. (2022). The Expression of Connexin 37, 40, 43, 45 and Pannexin 1 in the Early Human Retina and Choroid Development and Tumorigenesis. International Journal of Molecular Sciences. 23(11). 5918–5918. 9 indexed citations
8.
Šoljić, Violeta, et al.. (2022). Metformin and Thymoquinone Synergistically Inhibit Proliferation of Imatinib-Resistant Human Leukemic Cells. Frontiers in Pharmacology. 13. 867133–867133. 11 indexed citations
9.
Šoljić, Violeta, et al.. (2021). Decreased Expression of Cytotoxic Proteins in Decidual CD8+ T Cells in Preeclampsia. Biology. 10(10). 1037–1037. 8 indexed citations
10.
Vukojević, Katarina, et al.. (2021). Expression and localization of FGFR1, FGFR2 and CTGF during normal human lung development. Acta Histochemica. 123(5). 151719–151719. 2 indexed citations
11.
Filipović, Natalija, et al.. (2021). GREB1L, CRELD2 and ITGA10 expression in the human developmental and postnatal kidneys: an immunohistochemical study. Acta Histochemica. 123(2). 151679–151679. 7 indexed citations
12.
Durdov, Merica Glavina, Nenad Kunac, Marijan Saraga, et al.. (2019). Immunohistochemical expression pattern of RIP5, FGFR1, FGFR2 and HIP2 in the normal human kidney development. Acta Histochemica. 121(5). 531–538. 14 indexed citations
13.
Vukojević, Katarina, et al.. (2017). Decreased expression of MMP-9 in CD8+cells in placenta with severe preeclampsia. Biotechnic & Histochemistry. 92(4). 288–296. 4 indexed citations
15.
Filipović, Natalija, et al.. (2015). Expression pattern of RAGE and IGF-1 in the human fetal ovary and ovarian serous carcinoma. Acta Histochemica. 117(4-5). 468–476. 19 indexed citations
16.
Vukojević, Katarina, et al.. (2015). Co-expression of TTF-1 and neuroendocrine markers in the human fetal lung and pulmonary neuroendocrine tumors. Acta Histochemica. 117(4-5). 451–459. 9 indexed citations
17.
Vukojević, Katarina, et al.. (2013). The expression patterns of pro-apoptotic and anti-apoptotic factors in human fetal and adult ovary. Acta Histochemica. 115(6). 533–540. 12 indexed citations
18.
Durdov, Merica Glavina, et al.. (2012). IMP3 can predict aggressive behaviour of lung adenocarcinoma. Diagnostic Pathology. 7(1). 165–165. 29 indexed citations
19.
Šoljić, Violeta, et al.. (2012). ZAP-70 expression and proliferative activity in chronic lymphocytic leukemia. Leukemia & lymphoma. 54(6). 1171–1176. 6 indexed citations
20.
Šoljić, Violeta, et al.. (2012). The involvement of proliferation and apoptosis in the early human gonad development. Journal of Molecular Histology. 44(1). 55–63. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026